TDM-180935

N/A

Report date: 2024/11/29 15:41:34
NME

Base Information

Drug NameTDM-180935
Drug Alias NameTDM-180935
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase JAK1 inhibitorsTyrosine-protein kinase 2 inhibitors
TargetsTyrosine-protein kinase JAK1Tyrosine-protein kinase 2
Therapy Area/IndicationsDermatitis, Atopic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesJiaxing TechnoDerma Medicines Inc
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesTechnoDerma Medicines IncJiaxing TechnoDerma Medicines Inc
Inactive CompaniesN/A
Active IndicationsDermatitis, Atopic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A